Enveric Biosciences Inc (ENVB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2004 | 12-2003 | 12-2002 | 12-2001 | 12-2000 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -150 | -490 | 10 | -240 | 380 |
| Depreciation Amortization | 50 | 80 | 100 | 130 | 80 |
| Other Working Capital | 440 | 140 | -30 | -230 | -350 |
| Other Operating Activity | 0 | 20 | 0 | 0 | 30 |
| Operating Cash Flow | $340 | $-250 | $80 | $-340 | $140 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -4 | -1 | -70 | -20 | -40 |
| Other Investing Activity | -16 | -19 | -20 | -10 | -110 |
| Investing Cash Flow | $-20 | $-20 | $-90 | $-30 | $-150 |
| Cash Flows From Financing Activities | |||||
| Other Financing Activity | -40 | 5 | 0 | -220 | 450 |
| Financing Cash Flow | $-40 | $5 | $0 | $-220 | $450 |
| Beginning Cash Position | 590 | 850 | 870 | 1,460 | 1,020 |
| End Cash Position | 870 | 590 | 850 | 860 | 1,460 |
| Net Cash Flow | $280 | $-260 | $-10 | $-590 | $440 |
| Free Cash Flow | |||||
| Operating Cash Flow | 340 | -250 | 80 | -340 | 140 |
| Free Cash Flow | 340 | -250 | 80 | -340 | 140 |